Brain Tumor Treatments: Chemotherapy
Sponsored By
Buy Wine - fight brain tumors!
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Chemotherapy
Please scroll down past the trials to see pages on this site about this topic!
  Previous 25 Showing Treatment 26 to 50 of 1137 Next 25 Location Last Updated
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Phoenix, AZ USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Atlanta, GA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Wichita, KS USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Fargo, ND USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Seattle, WA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Allentown, PA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Marshfield, WI USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma San Antonio, TX USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Houston, TX USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Lambertville, MI USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Akron, OH USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Wynnewood, PA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Las Vegas, NV USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Philadelphia, PA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Norwich, CT USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Jacksonville, FL USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Cleveland, OH USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Sacramento, CA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Pomona, CA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Jacksonville, FL USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Boise, ID USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Harvey, IL USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma South Bend,, IN USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Cape Girardeau, MO USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Omaha, NE USA 04/13/2010

(Relevance) Page Title - click title to go to the page!

  (0.9017)   Medulloblastoma
  (0.8792)   Trials by NCT number
  (0.8658)   Chemotherapy For Brain Tumors
  (0.8510)   Brain Tumor Treatments: Chemotherapy
  (0.8510)   Trials without an NCT number
  (0.7967)   Brain Tumor Treatments: China PR
  (0.7967)   Brain Tumor Treatments: Netherlands
  (0.7967)   Brain Tumor Treatments: Nebraska
  (0.7967)   Brain Tumor Treatments: North Dakota
  (0.7967)   Brain Tumor Treatments: Montana
  (0.7967)   Brain Tumor Treatments: Mississippi
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7967)   Brain Tumor Treatments: Maine
  (0.7967)   Emerging Med Trials Matcher
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Brain Tumor Treatments: Kentucky
  (0.7967)   Brain Tumor Treatments: Kansas
  (0.7967)   Brain Tumor Treatments: Indiana
  (0.7967)   Brain Tumor Treatments: Idaho
  (0.7967)   Brain Tumor Treatments: Iowa
  (0.7967)   Brain Tumor Treatments: Hawaii
  (0.7742)   Brain Tumor Guide
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain tumor Chat room registration
  (0.7742)   Problem Report Received
  (0.7742)   Brain Tumor Chat Room Problem
  (0.7742)   Brain Tumor Treatments: North Carolina
  (0.7742)   Musella Foundation
  (0.7742)   Mohammad Abdollahian
  (0.7742)   Brain Tumor Treatments: Missouri
  (0.7742)   Brain Tumor Treatments: Minnesota
  (0.7742)   Brain Tumor Treatments: Michigan
  (0.7742)   TEST
  (0.7742)   virtualtrials.com/menu2006b.cfm
  (0.7742)   virtualtrials.com/menu2006.cfm
  (0.7742)   Meningioma List
  (0.7742)   Meningioma List
  (0.7742)   Memorials
  (0.7742)   Memorials
  (0.7742)   Memorial
  (0.7742)   Brain Tumor Treatments: Maryland
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Brain Tumor Treatments: Malaysia
  (0.7742)   Newsletter And Daily News Update!
  (0.7742)   Mailbox
  (0.7742)   Brain Tumor Treatments: Massachusetts
  (0.7742)   Brain Tumor Treatments: Less Toxics
  (0.7742)   Online Support Groups
  (0.7742)   Links (webTV version)
  (0.7742)   Add a Links to Brain Tumor Information
  (0.7742)   Add a Links to Brain Tumor Information
  (0.7742)   Letter Writing Campaign
  (0.7742)   Brain Tumor Treatments: Less Toxics
  (0.7742)   Brain Tumor Treatments: Less-Toxic
  (0.7742)   Brain Tumor Treatments: Louisiana
  (0.7742)   Karnofsky Score
  (0.7742)   Jim Racich Memorial
  (0.7742)   Stereotactic Radiosurgery
  (0.7742)   Mailing Lists
  (0.7742)   Mailing Lists
  (0.7742)   Brain Tumor Treatments: Japan
  (0.7742)   Brain Tumor Treatments: Italy
  (0.7742)   Brain Tumor Treatments: Israel
  (0.7742)   Brain Tumor Chat Room Question
  (0.7742)   Brain Tumor Chat room
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Immunotherapies, biological and targeted therapies
  (0.7742)   Immunotherapies, biological and targeted therapies
  (0.7742)   Image Guided Surgery
  (0.7742)   Brain Tumor Treatments: Illinois
  (0.7742)   IFN-Beta Gene Transfer
  (0.7742)   2003 Pediatric Brain Tumor Confernce
  (0.7742)   Video Library: Brainstorming Long Island 2004
  (0.7742)   Hockey fundraiser
  (0.7742)   Hockey fundraiser
  (0.7742)   Human Corticotropin-Releasing Factor (hCRF)
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain Tumor Chat room




Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites